The total return over the past 12 months is -8.78% vs. +16.94% for the S&P 500. So far it's up -38.00% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (8.71%) | (44.56%) | (76.00%) | (71.22%) | (60.45%) | N/A |
| Total Return CAGR | (8.78%) | (44.66%) | (76.02%) | (71.24%) | (60.47%) | N/A |
| Revenue CAGR | N/A | +25.99% | N/A | +47.88% | (2.52%) | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Palisade Bio, Inc. (PALI)
| Year | Start price | End price | PALI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.35 | $1.46 | (38.00%) | +14.51% | (52.51%) |
| 2025 | $1.65 | $2.35 | +42.86% | +17.72% | +25.14% |
| 2024 | $8.85 | $1.65 | (81.48%) | +24.89% | (106.37%) |
| 2023 | $78.00 | $8.85 | (88.66%) | +26.19% | (114.85%) |
| 2022 | $975.00 | $78.00 | (92.00%) | (18.17%) | (73.83%) |
| 2021 | $3,959.87 | $975.00 | (75.38%) | +28.74% | (104.12%) |
| 2020 | $4,454.85 | $3,959.87 | (11.11%) | +18.37% | (29.48%) |
| 2019 | $28,178.08 | $4,454.85 | (84.19%) | +31.22% | (115.41%) |
| 2018 | $154,794.94 | $28,178.08 | (81.80%) | (4.56%) | (77.24%) |
| 2017 | $319,963.51 | $154,794.94 | (51.62%) | +21.70% | (73.32%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
